Immunome, Inc. is a biopharmaceutical company utilizing its human memory B cell platform to discover and develop antibody therapeutics. The Company’s primary focus areas are oncology and infectious diseases.
Company Website: https://www.immunome.com
Immunome Inc.
Industry: Consumer Durables – Specialty Chemicals
Stock Symbol: IMNM – NASDAQ
Animal Usage: Animal Testing
Our Opinion
Immunome Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
Supporting Evidence:
The company stated in the following report that they exploit animals for product testing.
“Modulation of IL-38 levels in mouse models correlates with immune responsiveness, tumor growth” (Page 15) Read the full document
Company Description
Contact: info@immunome.com